New York, NY—June 1, 2025—Intelligencia AI is proud to announce that it has been named a winner in the 2025 Artificial Intelligence Excellence Awards, presented by the Business Intelligence Group. This prestigious recognition highlights the company’s commitment to innovation and its contributions to advancing artificial intelligence.

Portfolio Optimizer enables portfolio leaders, BD&L professionals and competitive intelligence functions to obtain consistent, accurate, and unbiased assessments of the likelihood of their drug’s success at every stage of drug development. The patented and award-winning Intelligencia Portfolio Optimizer has been recognized in the Pharmaceutical category for its groundbreaking advancements in AI, which have demonstrated a significant impact in the life sciences industry among portfolio, business development, life sciences, and R&D leaders.

The Artificial Intelligence Excellence Awards recognize the most innovative companies, technologies, and professionals who are driving the forefront of AI innovation. Winners are selected by a panel of industry experts who evaluate nominees based on their creativity, impact, and measurable success in AI-driven solutions.

“The AI industry is evolving rapidly, and it is through the efforts of companies like Intelligencia AI that we see real-world applications driving change,” said Russ Fordyce, CEO of the Business Intelligence Group. “Their work exemplifies the kind of innovation and leadership that is shaping the future of artificial intelligence.”

About Business Intelligence Group

The Business Intelligence Group was founded with the mission of recognizing true talent and superior performance in the business world. Unlike other industry award programs, these programs are judged by business executives having experience and knowledge. The organization’s proprietary and unique scoring system selectively measures performance across multiple business domains and rewards those companies whose achievements stand above those of their peers.